New research shows that masitinib limits neuronal damage in a model of neuroimmune-driven neurodegenerative disease
13/03/2024 – AB Science today announced the publication of new preclinical results for masitinib in neurodegenerative diseases
13/03/2024 – AB Science today announced the publication of new preclinical results for masitinib in neurodegenerative diseases
07/03/2024 – AB Science is providing a summary of the live webcast held on March 4, 2024, giving an update on AB Science development
06/03/2024 – AB Science announces that two financial analysis firms, DNA Finance and In Extenso Finance, have initiated coverage of the Company
04/03/2024 – Presentation of the AB Science webcast held on March 4, 2024
01/03/2024 – AB Science will host a live webcast on Monday March 4, 2024, from 6.30pm to 7.30pm CET